What changed today in Aesthetics & Longevity: 2 new studies, 1 trial update
Every new official record on the Aesthetics, Regenerative & Longevity Medicine desk since this morning, each linked to its primary source.
The signal
NPHLA tracked 3 new official records on this desk today: 2 new studies, 1 trial update.
Why this matters
New clearances, safety communications and research in aesthetic and regenerative medicine affect what practices offer, how they describe it and what patients are told.
What changed
- New research in International journal of pharmaceutics: “Extracellular matrix hydrogel modified by miR-21-overexpressing keratinocyte-derived exosomes accelerates burn wound healing”.[1]
- New trial registered: Comparison of Three Treatments for Myofascial Pain in Patients With Bruxism[2]
- New research in Aesthetic plastic surgery: “Efficacy and Safety of a Polycaprolactone-Based Injectable Filler for the Correction of Mild-to-Moderate Chin Retrusion in Adults Compared with No Treatment: A…”.[3]
- Also reported by American Med Spa Association: “A Med Spa Owner’s Real-World Guide to AI Employees: Podcast Transcript”.[4]
Who this affects
- Med spas
- Medical directors
- Prescribers
- Practice owners & operators
- Pharmacies
What to watch next
No new verified deadlines in today’s records. See Deadline Watch for upcoming dates.
NPHLA takeaway
These are factual summaries of official records with no interpretation. Open the primary documents for full details; NPHLA editors add analysis where developments warrant it.
Source file
- [1]
- [2]
- [3]
- [4]
Compiled automatically from primary official sources and peer-reviewed literature. Each line is a factual summary of a public record, linked to it — no interpretation is added. NPHLA links to sources and does not republish their text. Professional information only — not medical, legal or regulatory advice for any individual situation. Our standards.
Update timeline
- First published.
- Added 2 new official records.

